6-bromo-androstan-3,17-dione
← Previous: 6-bromo-androsta-1,4-diene-3,17-dione | 🏠 All Substances | 📊 Complete Table | Next: 6-monoacetylmorphine →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S4: Hormone and Metabolic Modulators (WADA Prohibited List S4: Hormone and Metabolic Modulators) |
| Added to Database | December 30, 2025 |
| Source Last Updated | July 12, 2024 |
| GUID | b7f7f4a5-ddb3-4324-b531-eb3a7d3705f8 |
External Resources
UNII: 5PCB3258DC
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H27BrO2 |
| Molecular Weight | 367.3 g/mol |
| IUPAC Name | (8R,9S,10R,13S,14S)-6-bromo-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
| InChIKey | CLQPFVWXHQYORP-USTCFPKVSA-N |
📊 Complete Table | 🏠 All Substances
Substance 116 of 880